Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Int. braz. j. urol ; 43(2): 289-303, Mar.-Apr. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-840832

RESUMEN

ABSTRACT Objectives We sought to determine whether disease representation in the Cochrane Database of Systematic Reviews (CDSR) reflects disease burden, measured by the Global Burden of Disease (GBD) Study as disability-adjusted life-years (DALYs). Materials and Methods Two investigators performed independent assessment of ten men’s health and urologic diseases (MHUDs) in CDSR for systematic review and protocol representation, which were compared with percentage of total 2010 DALYs for the ten conditions. Data were analyzed for correlation using Spearman rank analysis. Results Nine of ten MHUDs were represented by at least one CDSR review. There was a poor and statistically insignificant positive correlation between CDSR representation and disease burden (rho = 0.42, p = 0.23). CDSR representation was aligned with disease burden for three conditions, greater than disease burden for one condition, and less than disease burden for six conditions. Conclusions These results yield high-quality estimates to inform future research prioritization for MHUDs. While prioritization processes are complex and multi-faceted, disease burden should be strongly considered. Awareness of research priority setting has the potential to minimize research disparities on a global scale.


Asunto(s)
Humanos , Masculino , Enfermedades Urológicas , Literatura de Revisión como Asunto , Investigación Biomédica/tendencias , Investigación Biomédica/estadística & datos numéricos , Salud del Hombre/tendencias , Salud del Hombre/estadística & datos numéricos , Factores de Tiempo , Neoplasias Urológicas , Estadísticas no Paramétricas , Años de Vida Ajustados por Calidad de Vida , Carga Global de Enfermedades , Infertilidad Masculina
2.
Indian J Med Ethics ; 2015 Apr-Jun; 12 (2): 110-113
Artículo en Inglés | IMSEAR | ID: sea-180089

RESUMEN

A transparent and evidence-based priority-setting process promotes the optimal use of resources to improve health outcomes. Decision-makers and funders have begun to increasingly engage representatives of patients and healthcare consumers to ensure that research becomes more relevant. However, disadvantaged groups and their needs may not be integrated into the priority-setting process since they do not have a “political voice” or are unable to organise into interest groups. Equitable priority-setting methods need to balance patient needs, values, experiences with population-level issues and issues related to the health system.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA